ON DEMAND WEBINAR
Duration: 1 hour
Are you among the 43% of employers considering coverage of GLP-1s such as Wegovy for weight loss or Ozempic for diabetes medication for your workforce next year? If so, you need to ask yourself the following: Who should qualify for coverage? How do you monitor safe and effective use? Do you need to adjust your population health targets?
These questions can help you gain perspective on the true cost of diabetes, obesity and other chronic conditions and increase your understanding of a primary care’s critical role in a holistic care approach and the safe prescription of medications. In this webinar discussion, Accolade physicians discuss: